BeStock  
Markets › Compare › AQST vs BCRX

AQST vs BCRX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AQST · Aquestive Therapeutics$3.46 ▼ 6.61%
BCRX · BioCryst Pharmaceuticals$7.22 ▼ 1.37%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4476107138169Nov 24, '25May 26, '26Nov 20, '26
  • AQST -40.1%
  • BCRX +5.7%

Head to head

MetricAQSTBCRX
Price$3.46$7.22
Change today▼ 6.61%▼ 1.37%
Market cap$434.88M$1.86B
Return, 3 months-27.9%-25.4%
Return, year to date-46.4%-7.4%
Return, 1 year-39.5%+3.6%
P/E (TTM)––
P/B-6.1-4.7
P/E percentile vs own 5y45th70th
Dividend yield––
Revenue growth (YoY, latest qtr)-41.0%+13.1%
Net profit growth (YoY)-6.8%+193.9%
Gross margin65.3%97.9%
Operating margin-114.1%42.5%
Net margin-162.3%-37.4%
Return on equity––
Analyst target vs. price+167.3%+135.5%
Analyst buy share100%67%
RSI (14)3635
30-day volatility65.4%40.4%
Max drawdown, 1 year-55.4%-35.0%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BCRX is the largest of the group by market value.
  • BCRX has returned the most over the past year.
  • BCRX is growing revenue fastest.
  • BCRX keeps the most profit per dollar of sales.
  • BCRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top